- 04 June | MGP Strategy Series | GS Paper 4 (Ethics) with AIR 7 A.R. Rajah Mohaideen Click Here to register for the session →
- 04 June | GS Advance Program begins from 4th June 2026 | First 2 classes open to all Click Here to register for the event →
- 05 June | MGP Strategy Series | GS Paper 3 Strategy Session with AIR 406 Mannat Luthra Click Here to register for the session
- 06 June | Open Orientation on Essay Guidance Program (EGP 2026) Click Here to register →
- 07 June | Open Orientation for Current Affairs for Mains 2026 Click Here to register →
- 07 June | Sociology Optional Strategy Session with AIR 10 Ujjwal Priyank Click Here to register →
Contents
Source: The post is based on the article “Union Minister announces India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer” published in PIB on 1st September 2022
What is the News?
Union Minister Science & Technology has launched India’s first indigenously developed vaccine, “CERVAVAC” for the prevention of cervical cancer.
What is CERVAVAC Vaccine?
Doses: Two vaccine doses are supposed to be administered to teenage girls before they are sexually active. For older individuals, three doses are recommended.
Note: This vaccine can prevent an infection, but cannot clear it once it happens.
What is Cervical Cancer?
Cervical Cancer cases in India
Cervical cancer ranks as the 2nd most prevalent cancer in India and accounts for nearly one-fourth of the world’s cervical cancer deaths despite being largely preventable.
Current estimates indicate that every year approximately 1.25 lakhs women are diagnosed with cervical cancer and over 75,000 die from the disease in India.
Around 83% of invasive cervical cancers are attributed to HPVs 16 or 18 in India.
The most promising intervention for preventing cervical cancer is vaccination against human papillomavirus(HPV).
It is estimated that HPV types 16 and 18 (HPV-16 and HPV-18) together contribute to approximately 70% of all invasive cervical cancer cases worldwide.
